Search Within

Steven M Larson

Formats
  1. Journal Article (544)
  2. Meeting Abstract (350)
  3. Book Section (29)
  4. Conference Paper (23)
  5. Editorial (5)
  6. Review (4)
  7. Book Whole (3)
  8. Miscellaneous (1)
Groups
  1. GSK Faculty (959)
  2. Molecular Imaging and Therapy Service (959)
  3. Molecular Pharmacology and Chemistry Program Faculty (959)
  4. Radiology, Department of (959)
  5. Sloan Kettering Institute Faculty (959)
  6. Department of Medicine (386)

More Groups

People
  1. John Humm (185)
  2. Ronald Finn (184)
  3. Pat Zanzonico (112)
  4. Howard Scher (110)
  5. Nai-Kong Cheung (108)
  6. Chaitanya Divgi (103)

More People

Years
  1. 2025 (6)
  2. 2024 (8)
  3. 2023 (11)
  4. 2022 (23)
  5. 2021 (14)
  6. 2020 (18)

More Years

Publications
  1. Journal of Nuclear Medicine (294)
  2. Journal of Clinical Oncology (84)
  3. Clinical Cancer Research (34)
  4. Cancer Research (29)
  5. European Journal of Nuclear Medicine (24)
  6. European Journal of Nuclear Medicine and Molecular Imaging (22)

More Publications

Publishers
  1. Society of Nuclear Medicine (294)
  2. American Society of Clinical Oncology (85)
  3. American Association for Cancer Research (83)
  4. Springer (77)
  5. Elsevier Inc. (49)
  6. Lippincott Williams & Wilkins (31)

More Publishers

Results (959)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Self-assembling and disassembling (SADA) domain is critical to the binding, and anti-tumor efficacy of GD2-SADA
    Meeting Abstract

    Santich, B. H.; Kjellev, S. L.; Cheal, S.; Wang, L.; Gillberg, M.; Vadlamudi, M.; Ouattara, A. A.; Liebenberg, N.; Larsen, L. F.; Veach, D. R.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Establishment of efficacy of DOTA-based pretargeted radioimmunotherapy with a bivalent radiohapten for enhanced therapeutic indices
    Meeting Abstract

    Vaughn, B.; Veach, D.; Vargas, D. B.; Seo, S.; Punzalan, B.; Zanzonico, P.; Xu, H.; Guo, H. F.; Yang, G.; Ouerfelli, O.; more...
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Meeting Abstract

    Modak, S.; Pandit Taskar, N.; Kushner, B.; Zanzonico, P.; Humm, J.; Donzelli, M.; Lewis, J.; Lyashchenko, S.; Chu, B.; Larson, S.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • STARLITE 2: Phase 2 study of nivolumab plus (177)Lutetium-labeled anti-carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients (pts) with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Lee, C. H.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Characterization of a novel radiohapten capture system in car T cells for tracking in vivo and improving CAR T efficacy
    Meeting Abstract

    Kurtz, K.; Dacek, M.; Cheal, S.; Veach, D.; Qureshy, S.; Carter, L.; Eibler, L.; Verma, S.; McDevitt, M.; Punzalan, B.; more...
    Human Gene Therapy (2022)

    Fulltext@MSK | Save
  • A radiohapten capture system for CAR T cells that tracks them in vivo and improves efficacy
    Meeting Abstract

    Kurtz, K.; Eibler, L.; Dacek, M.; Carter, L.; Cheal, S.; Veach, D.; Qureshy, S.; Han, J.; Reynaud, E.; Verma, S.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Prospective evaluation of (18)F-FDG positron emission tomography in the preoperative staging of patients with hepatic colorectal metastases
    Journal Article

    Akhurst, T.; Gönen, M.; Baser, R. E.; Schwartz, L. H.; Tuorto, S.; Brody, L. A.; Covey, A.; Brown, K. T.; Larson, S. M.; Fong, Y.
    Hepatobiliary Surgery and Nutrition (2022)

    Fulltext@MSK | Save
  • Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Journal Article

    Kramer, K.; Pandit-Taskar, N.; Kushner, B. H.; Zanzonico, P.; Humm, J. L.; Tomlinson, U.; Donzelli, M.; Wolden, S. L.; Haque, S.; Dunkel, I.; more...
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Long-term survival from a phase 1 doseescalation trial using convection-enhanced delivery (CED) of radioimmunotherapeutic (124)I-omburtamab for treatment of diffuse intrinsic pontine glioma (DIPG)
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Tasker, N.; Haque, S.; Zanzonico, P.; Carrasquillo, J.; Lyashchenko, S. K.; Thakur, S. B.; Khakoo, Y.; Dunkel, I. J.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save